NIAID Banner Logo Image

Other Viruses Citation List: September 14 - September 27, 2012

Hepatitis C Virus

1. Combination of Fluvastatin with Pegylated Interferon/Ribavirin Therapy Reduces Viral Relapse in Chronic Hepatitis C Infected with HCV Genotype 1B. Atsukawa, M., A. Tsubota, C. Kondo, N. Itokawa, Y. Narahara, K. Nakatsuka, S. Hashimoto, T. Fukuda, Y. Matsushita, H. Kidokoro, T. Kobayashi, H. Kanazawa, and C. Sakamoto. Journal of Gastroenterology and Hepatology, 2012. [Epub ahead of print]; PMID[22989264].

[PubMed] OV_0914-092712.

2. Small Molecule Inhibitors of the Hepatitis C Virus-encoded NS5A Protein. Belda, O. and P. Targett-

Adams. Virus Research, 2012. [Epub ahead of print]; PMID[23009750].

[PubMed] OV_0914-092712.

3. Beta-D-2'-alpha-F-2'-beta-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide Prodrugs as Inhibitors of Hepatitis C Virus Replication: A Structure-Activity Relationship Study. Du, J., D. Bao, B.K. Chun, Y. Jiang, P. Ganapati Reddy, H.R. Zhang, B.S. Ross, S. Bansal, H. Bao, C. Espiritu, A.M. Lam, E. Murakami, C. Niu, H.M. Micolochick Steuer, P.A. Furman, M.J. Otto, and M.J. Sofia. Bioorganic & Medicinal Chemistry Letters, 2012. 22(18): p. 5924-5929; PMID[22892115].

[PubMed] OV_0914-092712.

4. Exploration of the in Vitro Antiviral Activity of a Series of New Pyrimidine Analogues on the Replication of HIV and HCV. Jafar, N.N., N.A. Al-Masoudi, S.J. Baqir, P. Leyssen, and C. Pannecouque. Antiviral Chemistry & Chemotherapy, 2012. [Epub ahead of print]; PMID[23010622].

[PubMed] OV_0914-092712.

5. Silymarin for HCV Infection. Polyak, S.J., N.H. Oberlies, E.I. Pecheur, P. Ferenci, and J.M. Pawlotsky. Antiviral Therapy, 2012. [Epub ahead of print]; PMID[23011959].

[PubMed] OV_0914-092712.

6. Conjugation of Cyclodextrin with Fullerene as a New Class of HCV Entry Inhibitors. Xiao, S.L., Q. Wang, F. Yu, Y.Y. Peng, M. Yang, M. Sollogoub, P. Sinay, Y.M. Zhang, L.H. Zhang, and D.M. Zhou. Bioorganic & Medicinal Chemistry, 2012. 20(18): p. 5616-5622; PMID[22884577].

[PubMed] OV_0914-092712.

HSV-1

7. A Natural Antiviral and Immunomodulatory Compound with Antiangiogenic Properties. Bueno, C.A., M.G. Lombardi, M.E. Sales, and L.E. Alche. Microvascular Research, 2012. [Epub ahead of print]; PMID[23006904].

[PubMed] OV_0914-092712.

8. Sterol Analogues with Diamide Side Chains Interfere with the Intracellular Localization of Viral Glycoproteins. Davola, M.E., F. Alonso, G.M. Cabrera, J.A. Ramirez, and A.A. Barquero. Biochemical and Biophysical Research Communications, 2012. [Epub ahead of print]; PMID[22982541].

[PubMed] OV_0914-092712.

9. Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV. Yoo, J.Y., J. Pradarelli, A. Haseley, J. Wojton, A. Kaka, A. Bratasz, C.A. Alvarez-Breckenridge, J.G. Yu, K. Powell, A.P. Mazar, T.N. Teknos, E.A. Chiocca, J.C. Glorioso, M. Old, and B. Kaur. Clinical Cancer Research, 2012. 18(18): p. 4931-4941; PMID[22753591].

[PubMed] OV_0914-092712.

Epstein Barr Virus

10. Resveratrol Inhibits Epstein Barr Virus Lytic Cycle in Burkitt's Lymphoma Cells by Affecting Multiple Molecular Targets. Alessandra, D.L., A. Giuseppe, L. Egidio, O. Giorgio, C. Francesca, and M. Elena. Antiviral Research, 2012. [Epub ahead of print]; PMID[22985630].

[PubMed] OV_0914-092712.

Citations from the ISI Web of Knowledge Listings for O.V.

11. Limited Effect on NS3-NS4A Protein Cleavage after Alanine Substitutions within the Immunodominant HLA-A2-Restricted Epitope of the Hepatitis C Virus Genotype 3a Non-Structural 3/4A Protease. Ahlen, G., A. Chen, B. Roe, T. Falkeborn, L. Frelin, W.W. Hall, M. Sallberg, and J. Soderholm. Journal of General Virology, 2012. 93: p. 1680-1686; ISI[000307746100007].

[WOS]. OV_0914-092712.

12. Inhibitory Effects of Fluvastatin on Hepatitis C Virus Involves the Doublecortin and Cam Kinase-like-1 (DCAMKL-1) Stem Cell Marker. Ali, N., H. Allam, T. Bader, R. May, S. Umar, and C.W. Houchen. Gastroenterology, 2012. 142(5): p. S696-S696; ISI[000306994303675].

[WOS]. OV_0914-092712.

13. Synthesis of New Pentaheterocyclic Ring Systems as Anti-androgene, anti-HCV and anti-H1N1 Agents. Farghaly, T.A., I.M. Abbas, M.M. Abdalla, and R.O.A. Mahgoub. Arkivoc, 2012: p. 57-70; ISI[000307877800006].

[WOS]. OV_0914-092712.

14. CVVS-732: A Conformational Modulator of NS5B Polymerase Acting a Potent HCV Inhibitor. Guedat, P., I. Valarche, M. Lahmar, A. Berecibar, L. Batard, A. Bertrand, A. Martin, A. Piessens, C. Fernagut, C. Freslon-Evain, L. Besnard, M. Ventura, T. Durand, C. Feray, and M. Mehtali. Gastroenterology, 2012. 142(5): p. S963-S963; ISI[000306994305342].

[WOS]. OV_0914-092712.

15. Boron Containing Compounds as Protease Inhibitors. Smoum, R., A. Rubinstein, V.M. Dembitsky, and M. Srebnik. Chemical Reviews, 2012. 112(7): p. 4156-4220; ISI[000306298800014].

[WOS]. OV_0914-092712.

16. Efficient Inhibition of HIV-1 Replication by an Artificial Polycistronic miRNA Construct. Zhang, T., T. Cheng, L.H. Wei, Y.J. Cai, A.E. Yeo, J.H. Han, Y.A. Yuan, J. Zhang, and N.S. Xia. Virology Journal, 2012. 9: p. 118; ISI[000307410000001].

[WOS]. OV_0914-092712.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2022